substance p has been researched along with Central Nervous System Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, X; Chai, S; Chen, Z; Dong, R; Ji, Z; Lai, K; Lv, H; Yue, J; Zhan, J; Zhang, H | 1 |
Douglas, SD; Manak, MM; Meshki, J; Moshkoff, DA; Nguyen, LT; Tebas, P; Tuluc, F | 1 |
Cooper, RR; Jones, KB; Mollano, AV; Morcuende, JA; Saltzman, CL | 1 |
Gerspacher, M | 1 |
Bouras, C; Constantinidis, J; Richard, J | 1 |
Barker, R | 1 |
4 review(s) available for substance p and Central Nervous System Disease
Article | Year |
---|---|
Bone and brain: a review of neural, hormonal, and musculoskeletal connections.
Topics: Arthropathy, Neurogenic; Bone and Bones; Brain; Calcitonin Gene-Related Peptide; Catecholamines; Central Nervous System Diseases; Denervation; Glutamic Acid; Humans; Neuropeptides; Peripheral Nervous System Diseases; Substance P; Vasoactive Intestinal Peptide | 2004 |
Selective and combined neurokinin receptor antagonists.
Topics: Animals; Central Nervous System Diseases; Drug Combinations; Gastrointestinal Diseases; Humans; Lung Diseases; Neurokinin A; Neurokinin B; Pain; Receptors, Tachykinin; Substance P; Urologic Diseases; Vomiting | 2005 |
Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
Topics: Alzheimer Disease; Brain Mapping; Central Nervous System Diseases; Cholecystokinin; Enkephalins; Humans; Huntington Disease; Limbic System; Nerve Tissue Proteins; Neurotransmitter Agents; Parkinson Disease; Schizophrenia; Substance P; Substance-Related Disorders | 1983 |
Substance P and neurodegenerative disorders. A speculative review.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Autoimmunity; Central Nervous System Diseases; Humans; Parkinson Disease; Substance P | 1991 |
2 other study(ies) available for substance p and Central Nervous System Disease
Article | Year |
---|---|
Effect of transient receptor potential vanilloid-1 on cough hypersensitivity induced by particulate matter 2.5.
Topics: Animals; Capillary Permeability; Capsaicin; Central Nervous System Diseases; Cough; Guinea Pigs; Herpesvirus 1, Suid; Hypersensitivity; Male; Particulate Matter; Respiratory Hypersensitivity; Signal Transduction; Substance P; TRPV Cation Channels; Vagus Nerve | 2016 |
Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.
Topics: Anti-HIV Agents; Aprepitant; Blood-Brain Barrier; Cells, Cultured; Central Nervous System Diseases; Drug Interactions; HIV Infections; HIV-1; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2010 |